Boehringer Ingelheim GmbH Release: Type 2 Diabetes: Physicians Worldwide Agree Early Conversations Are Crucial In The Management Of Condition

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

INGELHEIM, Germany & INDIANAPOLIS, US--(BUSINESS WIRE)--Non-US and Non-UK
The first insights from IntroDia™ presented at the American Diabetes Association’s (ADA) 74th Scientific Sessions®, showed that over three quarters (76-100 percent across 26 countries) of 6,753 physicians surveyed agree that conversations at diagnosis impact the way people with Type 2 Diabetes (T2D) accept their condition and their treatment adherence.1 Despite the importance of these conversations, the preliminary data also indicated many physicians report a variety of challenges during the diagnosis conversations.1

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC